Showing results (1-10 of 93) with videos related to

Sort By:
Pageof 10
Mini Reviews in Medicinal Chemistry|July 20, 2005
CB1 and CB2 cannabinoid receptor binding studies based on modeling and mutagenesis approachesSilvia Ortega-Gutiérrez, María L López-Rodríguez
Mini Reviews in Medicinal Chemistry|October 8, 2003
VR1 receptor modulators as potential drugs for neuropathic painMaría L López-Rodríguez, Alma Viso, Silvia Ortega-Gutiérrez
Seminars in Cancer Biology|February 8, 2018
Blocking Ras inhibition as an antitumor strategyNagore I Marín-Ramos, Silvia Ortega-Gutiérrez, María L López-Rodríguez
Immunopharmacology|April 1, 1995
The presence and cytotoxicity of CD16+ CD2- subset from PBL and NK cells in long-term IL-2 cultures enhanced by Prothymosin-alphaO J Cordero, C Sarandeses, J L López-Rodríguez, et al.
Revista De Neurologia|July 28, 2006
[Neurological manifestations in critically ill patients]L López-Rodríguez, F G Hidalgo-Alquicira, A J Mimenza-Alvarado
Journal of Computer-Aided Molecular Design|March 10, 1998
Comparative receptor mapping of serotoninergic 5-HT3 and 5-HT4 binding sitesM L López-Rodríguez, M J Morcillo, B Benhamú, et al.
Mini Reviews in Medicinal Chemistry|January 11, 2005
Involvement of cannabinoids in cellular proliferationMaría L López-Rodríguez, Alma Viso, Silvia Ortega-Gutiérrez, et al.
Biochemical Pharmacology|July 31, 2018
Monoacylglycerol lipase (MAGL) as a promising therapeutic targetAna Gil-Ordóñez, Mar Martín-Fontecha, Silvia Ortega-Gutiérrez, et al.
Lymphokine and Cytokine Research|June 1, 1994
Interleukin-2 killer cells: in vitro evaluation of combination with prothymosin alphaJ L López-Rodríguez, O J Cordero, C Sarandeses, et al.
Current Medicinal Chemistry|April 12, 2002
Arylpiperazine derivatives acting at 5-HT(1A) receptorsM L López-Rodríguez, D Ayala, B Benhamú, et al.
Pageof 10